MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-01-2026
Aspira Women's Health ROCE Ratio 2011-2026 | AWH
Annual ROCE Ratio Aspira Women's Health
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114.15 | 635.12 | -486.78 | -108.03 | -136.17 | -155.11 | -134.21 | -213.6 | -273.98 | -109.31 | -99.77 | -32.73 | -173.15 | -151.62 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 635.12 | -486.78 | -94.66 |
Quarterly ROCE Ratio Aspira Women's Health
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5733.49 | 5815.58 | 612.57 | 1237.16 | 1713.17 | 2413.1 | 683.58 | 606.82 | -94.52 | -971.09 | -177.49 | -202.66 | -151.07 | -110.1 | -53.65 | -97.7 | -116.58 | -138.71 | -122.51 | -166.57 | -166.59 | -176.49 | -135.89 | -172.84 | -165.74 | -158.85 | -118.97 | -192.32 | -228.72 | -255.2 | -220.16 | -312.27 | -331.03 | -362.14 | -322.22 | -351.53 | -288.74 | -216.4 | -81.23 | -110.26 | -109.97 | -111.21 | -78.64 | -87.3 | -66.93 | -45.98 | -26.29 | -75.53 | -116.12 | -186.86 | -174.27 | -217.97 | -212.43 | -187.8 | -140.66 | -43.7 | -54.03 | -42.93 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5815.58 | -971.09 | 173.56 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
25.0 | $ 115.48 | 0.82 % | $ 35.1 B |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 16.2 | -0.61 % | $ 175 M |  China |
|
Biodesix
BDSX
|
-41.6 | $ 15.07 | 2.1 % | $ 1.95 B | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.84 | -0.84 % | $ 690 M | USA |
 |
DarioHealth Corp.
DRIO
|
-36.38 | $ 8.4 | 3.7 % | $ 33.5 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
-75.05 | $ 1.2 | 0.84 % | $ 6.53 M | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 173.89 | -0.58 % | $ 8.62 B | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
DexCom
DXCM
|
33.2 | $ 62.22 | -0.24 % | $ 24.3 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.82 | 2.31 % | $ 509 M | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.17 | -0.91 % | $ 4.98 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Celcuity
CELC
|
-171.24 | $ 112.63 | -0.27 % | $ 5.27 B | USA |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 198.02 | 0.17 % | $ 22 B | USA |
 |
Guardant Health
GH
|
440.3 | $ 93.83 | 2.94 % | $ 11.8 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 76.1 | 0.53 % | $ 5.14 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 498.34 | 1.81 % | $ 14.4 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 259.94 | -1.11 % | $ 26 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 114.19 | 2.49 % | $ 9.42 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
61.76 | $ 569.55 | 0.87 % | $ 45.8 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.41 | 0.21 % | $ 2.04 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 127.38 | 0.59 % | $ 20.3 B | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 173.26 | 0.5 % | $ 29.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.34 | -0.74 % | $ 402 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.11 | -0.66 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 273.72 | 0.36 % | $ 22.8 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.75 | 3.49 % | $ 440 M | USA |
 |
Sotera Health Company
SHC
|
70.91 | $ 14.96 | 0.61 % | $ 4.25 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.0 | 3.23 % | $ 1.02 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.16 | -1.04 % | $ 384 M | USA |